The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism.

Hertz-Picciotto I, Croen LA, Hansen R, Jones CR, van de Water J, Pessah IN. · 2006

Read The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. by Hertz-Picciotto I, Croen LA, Hansen R, Jones CR, van de Water J, Pessah IN. (2006) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1513329.txt.

Introduction

Autism likely grows from a mix of genes and surroundings. Hertz-Picciotto and co-authors launched the CHARGE study in 2006 to sort those causes. Past links to chemicals and viruses rested on weak methods. Twin and family studies support inherited risk, yet early life conditions may switch that risk on or off.

CHARGE compares children with autism to others, gathering deep detail. It collects development tests, medical records, surveys, and body samples. Labs linked to the study probe immune function, chemical loads, and gene activity. The design also covers children with developmental delay. Hertz-Picciotto aims to test how exposures and genes interact, not just each alone.

Catalog record

CREATORHertz-Picciotto I, Croen LA, Hansen R, Jones CR, van de Water J, Pessah IN.
YEAR2006
COLLECTIONPAPERS
FORMATTXT
FILE SIZE51 KB
LICENSECC0 1.0 Universal
RIGHTSCC0
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC1513329

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The CHARGE Study: An Epidemiologic Investigation of Genetic and Environmental Factors Contributing to Autism By Irva Hertz-Picciotto, Lisa A Croen, Robin Hansen, Carrie R Jones, Judy van de Water, Isaac N Pessah Published in: Environmental Health Perspectives DOI: 10.1289/ehp.8483 ABSTRACT Abstract Causes and contributing factors for autism are poorly understood. Evidence suggests that prevalence is rising, but the extent to which diagnostic changes and improvements in ascertainment contribute to this increase is unclear. Both genetic and environmental factors are likely to contribute etiologically. Evidence from twin, family, and genetic studies supports a role for an inherited predisposition to the development of autism. Nonetheless, clinical, neuroanatomic, neurophysiologic, and epidemiologic studies suggest that gene penetrance and expression may be influenced, in some cases strongly, by the prenatal and early postnatal environmental milieu. Sporadic studies link autism to xenobiotic chemicals and/or viruses, but few methodologically rigorous investigations have been undertaken. In light of major gaps in understanding of autism, a large case–control investigation of underlying environmental and genetic causes for autism and triggers of regression has been launched. The CHARGE (Childhood Autism Risks from Genetics and Environment) study will address a wide spectrum of chemical and biologic exposures, susceptibility factors, and their interactions. Phenotypic variation among children with autism will be explored, as will similarities and differences with developmental delay. The CHARGE study infrastructure includes detailed developmental assessments, medical information, questionnaire data, and biologic specimens. The CHARGE study is linked to University of California–Davis Center for Children’s Environmental Health laboratories in immunology, xenobiotic measurement, cell signaling, genomics, and proteomics. The goals, study design, and data collection protocols are described, as well as preliminary demographic data on study participants and on diagnoses of those recruited through the California Department of Developmental Services Regional Center System. Keywords: autism, autistic spectrum disorder, developmental delay, environment, genetics, mental retardation, pervasive developmental disorder Autism is a serious neurodevelopmental disorder characterized by impairments in social interaction, abnormalities in verbal and nonverbal communication, and restricted, stereotyped interests and behaviors (American Psychiatric Association 1994). Although a large proportion of individuals with autism manifest abnormal development from birth, a subset of at least 20–30% experience a regression with onset between 18 and 24 months of age after a period of apparently normal development (Lainhart et al. 2002). Autistic disorder is the most severe form of autism spectrum disorders (ASDs), which include Asperger’s syndrome and pervasive developmental disorders (PDDs) not otherwise specified. Approximately 70% of individuals with autistic disorder have some degree of mental retardation, and about half are nonverbal or have very impaired speech. Seizures are present by adolescence in about 30% of children with ASD, and between 5 and 10% of autism cases occur in association with other serious medical conditions such as fragile X, tuberous sclerosis, and Angelman’s syndrome (Fombonne 2003). Gastrointestinal problems and sleep disturbances are also thought to be common comorbidities; however, population-based prevalence estimates for these conditions are currently lacking. Males are four times as likely as females to have autism, but this ratio approaches one among individuals with severe cognitive impairment (Gillberg and Wing 1999). Most individuals with autism cannot live independently as adults (Rapin 1999). Over the past 20 years, the prevalence of autism has reportedly risen, with much public debate surrounding the reasons for this increase. Early reports estimated prevalence at 4–5 per 10,000 births (Fombonne 1999). Data published in the last few years suggest that autistic disorder occurs in at least 1–2 per 1,000 births, and the prevalence of the broader autism spectrum may be as high as 4–6 per 1,000 (Chakrabarti and Fombonne 2005; Yeargin-Allsopp et al. 2003). The causes and contributing factors for autism are poorly understood. The number of children with a diagnosis of autism as determined by the California Department of Developmental Services (DDS) has been rising continuously for over a decade (California DDS 2003). Although diagnostic changes and improvements in detection probably contribute to this increase (Chakrabarti and Fombonne 2005; Croen et al. 2002), a true rise in incidence may also be occurring (Blaxill et al. 2003). Evidence for genetic causes is strong, yet concordance in monozygotic twins suggests that a minimum of 40% of autism cases are likely to have an environmental cause. No single gene has yet been specifically linked to autism with replicability, but the disorder is believed to be polygenic. A few specific environmental factors are associated with autistic behaviors—prenatal exposures to thalidomide (Rodier and Hyman 1998), valproic acid (Christianson et al. 1994), or rubella (Chess et al. 1978)—but these are likely to play a negligible role, if any, in incident cases in Western countries over the last decade or so. Mechanisms of pathogenesis have yet to be delineated. Contrary to early beliefs that autism resulted from bad parent–child interactions (Bettelheim 1967), it is now widely accepted that aberrant brain development underlies autism pathogenesis (Bauman and Kemper 2003; Courchesne et al. 1988; Piven et al. 1990; Rodier et al. 1997). Autopsy studies demonstrate structural changes in the brain, and imaging and electrophysiology investigations reveal neurophysiologic differences in information processing between children with autism and those with typical development (Dawson et al. 2002; Maziade et al. 2000; McPartland et al. 2004; Rapin and Dunn 2003; Rosenhall et al. 2003). Neuroimmunomodulatory factors may also play a role (Silva et al. 2004; Vargas et al. 2005). Cytokine profiles, lymphocyte activation, and other immunologic parameters differ between individuals with and without autism (Ashwood and Van de Water 2004a, 2004b; Croonenberghs et al. 2002). Distributions of neuropeptides and neurotrophins at birth appeared to be altered among children who later developed autism (Nelson et al. 2001). Results from twin and family studies suggest a strong genetic contribution to the etiology of autism. Beginning with the classic work by Folstein and Rutter (1977), data from three population-based twin studies have demonstrated a higher concordance rate among monozygotic compared with dizygotic twins (Cook 1998). Strong familial aggregation of autism has also been demonstrated. The sibling recurrence risk (i.e., the probability of developing autism given a person’s sibling is autistic) has been estimated at 2–14% (Jorde et al. 1990; Ritvo et al. 1989; Smalley et al. 1988), a 10- to 20-fold increase over the general population prevalence. A family history of social deficits, language abnormalities, and psychiatric disorders has also been observed in case–control and clinic-based studies (Folstein and Rutter 1988; Piven and Palmer 1999). Autism co-occurs with several known genetic disorders, such as tuberous sclerosis (Smalley 1998), Angelman syndrome (Steffenburg et al. 1996), phenylketonuria, Joubert syndrome (Ozonoff et al. 1999), and Möbius syndrome (Johansson et al. 2001), and chromosomal abnormalities such as fragile X syndrome (Reiss and Freund 1990). More than 90% of autism cases, however, have none of the above syndromes. Linkage, association, and cytogenetic studies have been conducted. Numerous candidate genes for autism have been suggested based on their functional role, location within candidate chromosome regions, and positive associations with the disease (Korvatska et al. 2002). Replication of findings has been elusive (Wassink et al. 2004), probably because of the polygenic etiology, heterogeneity of the phenotype, and, assuming a role for gene–environment interaction, variation in exposure distributions across populations. An epigenetic mechanism related to Rett syndrome is also plausible (Samaco et al. 2005). Genomewide scans to identify regions marked by

Read the complete text